<i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid Carcinoma

The ability of cancer to metastasize is regulated by various signaling pathways, including transforming growth factor β (TGFβ), also implicated in the upregulation of Snail-1 transcription factor in malignant neoplasms. B-type Raf kinase gene (BRAF)<sup>V600E</sup>, the most common drivi...

Full description

Bibliographic Details
Main Authors: Katarzyna Wieczorek-Szukala, Janusz Kopczynski, Aldona Kowalska, Andrzej Lewinski
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/9/2701
_version_ 1797556599805444096
author Katarzyna Wieczorek-Szukala
Janusz Kopczynski
Aldona Kowalska
Andrzej Lewinski
author_facet Katarzyna Wieczorek-Szukala
Janusz Kopczynski
Aldona Kowalska
Andrzej Lewinski
author_sort Katarzyna Wieczorek-Szukala
collection DOAJ
description The ability of cancer to metastasize is regulated by various signaling pathways, including transforming growth factor β (TGFβ), also implicated in the upregulation of Snail-1 transcription factor in malignant neoplasms. B-type Raf kinase gene (BRAF)<sup>V600E</sup>, the most common driving mutation in papillary thyroid carcinoma (PTC), induces epithelial to mesenchymal transition (EMT) in thyroid cancer cells through changes in the Snail-1 level, increasing cell migration and invasion. However, little is known about the mechanism of Snail-1 and BRAF<sup>V600E</sup> relations in humans. Our study included 61 PTC patients with evaluated BRAF<sup>V600E</sup> mutation status. A total of 18 of those patients had lymph node metastases—of whom 10 were BRAF<sup>V600E</sup> positive, and 8 negative. Our findings indicate that the expression of Snail-1, but not TGFβ1, correlates with the metastatic phenotype in PTC. This is the first piece of evidence that the upregulation of Snail-1 corresponds with the presence of BRAF<sup>V600E</sup> mutation and increased expression of Snail-1 in metastatic PTC samples is dependent on BRAF<sup>V600E</sup> mutation status.
first_indexed 2024-03-10T17:04:08Z
format Article
id doaj.art-a5e82426e00948efaaab8119f0acad97
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T17:04:08Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-a5e82426e00948efaaab8119f0acad972023-11-20T10:51:48ZengMDPI AGJournal of Clinical Medicine2077-03832020-08-0199270110.3390/jcm9092701<i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid CarcinomaKatarzyna Wieczorek-Szukala0Janusz Kopczynski1Aldona Kowalska2Andrzej Lewinski3Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, 93-338 Lodz, PolandDepartment of Pathology, Holy Cross Cancer Center, 25-734 Kielce, PolandEndocrinology Clinic, Holy Cross Cancer Center, 25-734 Kielce, PolandDepartment of Endocrinology and Metabolic Diseases, Medical University of Lodz, 93-338 Lodz, PolandThe ability of cancer to metastasize is regulated by various signaling pathways, including transforming growth factor β (TGFβ), also implicated in the upregulation of Snail-1 transcription factor in malignant neoplasms. B-type Raf kinase gene (BRAF)<sup>V600E</sup>, the most common driving mutation in papillary thyroid carcinoma (PTC), induces epithelial to mesenchymal transition (EMT) in thyroid cancer cells through changes in the Snail-1 level, increasing cell migration and invasion. However, little is known about the mechanism of Snail-1 and BRAF<sup>V600E</sup> relations in humans. Our study included 61 PTC patients with evaluated BRAF<sup>V600E</sup> mutation status. A total of 18 of those patients had lymph node metastases—of whom 10 were BRAF<sup>V600E</sup> positive, and 8 negative. Our findings indicate that the expression of Snail-1, but not TGFβ1, correlates with the metastatic phenotype in PTC. This is the first piece of evidence that the upregulation of Snail-1 corresponds with the presence of BRAF<sup>V600E</sup> mutation and increased expression of Snail-1 in metastatic PTC samples is dependent on BRAF<sup>V600E</sup> mutation status.https://www.mdpi.com/2077-0383/9/9/2701PTCthyroidmetastasisSnail-1BRAF<sup>V600E</sup>
spellingShingle Katarzyna Wieczorek-Szukala
Janusz Kopczynski
Aldona Kowalska
Andrzej Lewinski
<i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid Carcinoma
Journal of Clinical Medicine
PTC
thyroid
metastasis
Snail-1
BRAF<sup>V600E</sup>
title <i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid Carcinoma
title_full <i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid Carcinoma
title_fullStr <i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid Carcinoma
title_full_unstemmed <i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid Carcinoma
title_short <i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid Carcinoma
title_sort i snail 1 i overexpression correlates with metastatic phenotype in braf sup v600e sup positive papillary thyroid carcinoma
topic PTC
thyroid
metastasis
Snail-1
BRAF<sup>V600E</sup>
url https://www.mdpi.com/2077-0383/9/9/2701
work_keys_str_mv AT katarzynawieczorekszukala isnail1ioverexpressioncorrelateswithmetastaticphenotypeinbrafsupv600esuppositivepapillarythyroidcarcinoma
AT januszkopczynski isnail1ioverexpressioncorrelateswithmetastaticphenotypeinbrafsupv600esuppositivepapillarythyroidcarcinoma
AT aldonakowalska isnail1ioverexpressioncorrelateswithmetastaticphenotypeinbrafsupv600esuppositivepapillarythyroidcarcinoma
AT andrzejlewinski isnail1ioverexpressioncorrelateswithmetastaticphenotypeinbrafsupv600esuppositivepapillarythyroidcarcinoma